Praxis Precision Medicines (PRAX) Enterprise Value: 2022-2025
Historic Enterprise Value for Praxis Precision Medicines (PRAX) over the last 4 years, with Sep 2025 value amounting to $848.3 million.
- Praxis Precision Medicines' Enterprise Value rose 27.62% to $848.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$173.6 million, marking a year-over-year decrease of 819.74%. This contributed to the annual value of $1.0 billion for FY2024, which is 850.20% up from last year.
- Per Praxis Precision Medicines' latest filing, its Enterprise Value stood at $848.3 million for Q3 2025, which was up 52.78% from $555.2 million recorded in Q2 2025.
- Praxis Precision Medicines' 5-year Enterprise Value high stood at $1.0 billion for Q4 2024, and its period low was -$52.9 million during Q2 2023.
- Its 3-year average for Enterprise Value is $421.7 million, with a median of $435.6 million in 2025.
- Per our database at Business Quant, Praxis Precision Medicines' Enterprise Value tumbled by 195.35% in 2023 and then skyrocketed by 1,661.36% in 2024.
- Over the past 4 years, Praxis Precision Medicines' Enterprise Value (Quarterly) stood at $50.5 million in 2022, then surged by 116.99% to $109.6 million in 2023, then spiked by 850.20% to $1.0 billion in 2024, then grew by 27.62% to $848.3 million in 2025.
- Its last three reported values are $848.3 million in Q3 2025, $555.2 million for Q2 2025, and $435.6 million during Q1 2025.